Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,435	8,412	8,351	5,720	5,368	7,770
Market Cap Growth	198.58%	0.74%	46.00%	6.56%	-30.92%	-60.53%
Enterprise Value	25,316	9,289	9,299	9,130	7,738	7,962
Last Close Price	42.42	32.84	32.60	22.33	20.95	30.33
PE Ratio	19.16	16.38	3.80	66.05	-	7.79
PS Ratio	6.17	2.12	1.20	1.35	4.79	2.79
PB Ratio	2.70	0.93	0.96	0.83	0.73	1.28
P/TBV Ratio	3.15	1.08	1.17	1.71	1.19	2.00
P/FCF Ratio	-	-	5.70	4.48	-	21.43
P/OCF Ratio	256.79	88.41	4.53	2.98	-	5.04
EV/Sales Ratio	6.39	2.34	1.34	2.16	6.90	2.86
EV/EBITDA Ratio	22.34	8.29	2.66	11.68	-	7.06
EV/EBIT Ratio	35.55	13.05	3.03	25.02	-	8.04
EV/FCF Ratio	-27.07	-	6.35	7.15	-	21.96
Debt / Equity Ratio	0.26	0.26	0.33	0.63	0.53	0.59
Debt / EBITDA Ratio	2.10	2.10	0.82	5.46	-	3.15
Debt / FCF Ratio	-	-	1.96	3.38	-	9.86
Net Debt / Equity Ratio	0.10	0.10	0.12	0.43	0.34	0.19
Net Debt / EBITDA Ratio	0.79	0.79	0.30	3.77	-9.98	1.02
Net Debt / FCF Ratio	-0.94	-0.94	0.70	2.31	-2.02	3.16
Asset Turnover	0.30	0.30	0.51	0.33	0.09	0.24
Inventory Turnover	1.76	1.76	3.62	3.02	1.31	1.20
Quick Ratio	1.29	1.29	0.87	0.46	1.36	0.64
Current Ratio	1.77	1.77	1.40	1.01	1.66	0.78
Return on Equity (ROE)	5.87%	5.87%	26.50%	0.81%	-10.57%	17.22%
Return on Assets (ROA)	3.32%	3.32%	14.16%	1.80%	-2.85%	5.35%
Return on Invested Capital (ROIC)	5.99%	6.14%	27.75%	3.85%	-6.47%	12.62%
Return on Capital Employed (ROCE)	7.00%	7.00%	33.20%	4.60%	-4.90%	15.40%
Earnings Yield	2.10%	6.11%	26.29%	1.51%	-13.44%	12.83%
FCF Yield	-3.83%	-11.12%	17.54%	22.33%	-23.30%	4.67%
Dividend Yield	13.55%	-	-	-	-	1.49%
Payout Ratio	-	-	-	-	-	26.21%
Buyback Yield / Dilution	-	-	-	-	20.42%	-9.51%
Total Shareholder Return	13.55%	-	-	-	20.42%	-8.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.